Healthcare Triangle is trading 5.81% down at $6.41 on October 28, 2026; available reporting does not identify a specific catalyst for the decline.

  • The latest major company news was an October 26 implementation of a 1-for-20 reverse split, intended to help regain Nasdaq’s minimum-bid compliance.
  • A Nasdaq hearing is scheduled for November 5; the earlier reverse split news does not establish why shares are down today.
  • The broader market was nearly flat, offering no clear market-wide explanation.